There is no antivenom available for species 'Gloydius monticola'. Availability was determined by analyzing specifications of antivenoms of the following sources:1. WCH Clinical Toxinology Resources (n=98), 2. WHO Venomous snakes distribution and species risk categories (n=100) and 3. other (n=6).
Is there an antivenom of another species or subspecies of genus 'Gloydius' occurring in the same geographic region [North Asia] ?- Gloydius blomhoffii [Russia, North Asia]
- Mamushi Antivenom (Kaketsuken)
Manufacturer: The Chemo-Sero-Therapeutic Research Institute (Kaketsuken), Japan, Holding centres: 0
- Gloydius blomhoffii blomhoffii [Russia, North Asia]
- Mamushi Antivenom (Kaketsuken)
Manufacturer: The Chemo-Sero-Therapeutic Research Institute (Kaketsuken), Japan, Holding centres: 0 - Mamushi Antivenom (Tageda)
Manufacturer: Takeda Chemical Industries, Japan, Holding centres: 0
- Gloydius brevicaudus [North Asia]
- Agkistrodon (Salmusa) Antivenom
Manufacturer: Korea Vaccine Co. Ltd., Republic of Korea, Holding centres: 0 - Mamushi Antivenom (Kaketsuken)
Manufacturer: The Chemo-Sero-Therapeutic Research Institute (Kaketsuken), Japan, Holding centres: 0
- Gloydius halys [Russia, North Asia, West Asia]
- Polyvalent Snake Antivenin
Manufacturer: Razi Serum and Vaccine Research Institute, Iran, Holding centres: 0 - Purified Agkistrodon halys Antivenom
Manufacturer: Shanghai Institute of Biological Products, China, Holding centres: 0
- Gloydius intermedius [Russia, North Asia, West Asia]
- Agkistrodon (Salmusa) Antivenom
Manufacturer: Korea Vaccine Co. Ltd., Republic of Korea, Holding centres: 0
- Gloydius ussuriensis [Russia, North Asia]
- Agkistrodon (Salmusa) Antivenom
Manufacturer: Korea Vaccine Co. Ltd., Republic of Korea, Holding centres: 0
|